Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics in neuroendocrine tumors of the pancreas.

JOP : Journal of the pancreas - 28 Jul 2014

Rizvi Syed Mujtaba, Wong Joyce, Saif Muhammad Wasif, Jia Yuxia

Abstract excerpt

Neuroendocrine tumors (NETs) arise from cells distributed throughout the endocrine system. Although, NETs are heterogeneous in their behavior, they tend to be more aggressive when arising in the pancreas. Pancreatic NET (panNET) represents three percent of all primary pancreatic neoplasms. Symptomatic and progressive panNETs are generally treated with cytotoxic chemotherapy, whereas molecular targeted therapy is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Modification Methylases
Share to DNA Repair Enzymes
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Share to Pharmacogenetics

Share to Proto-Oncogene Proteins c-met

Share to Ribonucleoside Diphosphate Reductase

Source

Identifiers

PMID: 25076325
DOI: 10.6092/1590-8577/2659

Genes

MET
MGMT
RRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics in neuroendocrine tumors of the pancreas.PMID 25076325Read ↗

Genetics of pancreatic neuroendocrine tumors: implications for the clinic.Semantic proximity Read ↗

Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis.Semantic proximity Read ↗

Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification.Semantic proximity Read ↗

Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors.Semantic proximity Read ↗

Molecular Basis of Pancreatic Neuroendocrine TumorsSemantic proximity Read ↗

Genetic and epigenetic alterations in pancreatic neuroendocrine tumorsSemantic proximity Read ↗

Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges.Semantic proximity Read ↗

Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical PracticeSemantic proximity Read ↗

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the FutureSemantic proximity Read ↗

Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline ActionabilitySemantic proximity Read ↗

Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panelSemantic proximity Read ↗

Genetics of Pancreatic Neuroendocrine Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.